
Nouvelles et événements

Raffles Medical Group Deepens Bench Strength and Appoints Senior Leadership for Raffles China Healthcare
2025-03-07
Raffles Medical Group Reports 4.3% Growth for PATMI to S$31.6 million in 2H2024
2025-03-07
RafflesMedicalGroup Audited Result Announcement For 2022
2023-02-27
The Directors are pleased to recommend a final ordinary dividend of 3.8 cents per share for FY 2022 in view of the Group′s strong performance, an increase of 35.7 per cent as compared to the previous year.